FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2050538748> ?p ?o ?g. }

• W2050538748 endingPage "1167" @default.
• W2050538748 startingPage "1162" @default.
• W2050538748 abstract "A dozen studies have been published showing that opiate antagonists suppress alcohol drinking in animals, and two independent placebo-controlled, double-blind clinical trials of naltrexone found this agent was associated with decreased alcohol craving and consumption in alcohol-dependent patients. Nalmefene is a newer opiate antagonist that has a number of potential advantages over naltrex-one in the treatment of alcoholism, including no dose-dependent association with liver toxicity and more effective binding to central opiate receptors. Consequently, a double-blind pilot study was conducted to gather preliminary data on the safety and efficacy of nalmefene for reducing alcohol consumption in alcohol-dependent subjects. Twenty-one alcohol-dependent subjects meeting admission criteria were randomly assigned to 12 weeks of double-blind treatment with 40 mg nalmefene, 10 mg nalmefene, or placebo, resulting in 7 patients/treatment group. Nalmefene was well tolerated, with no serious adverse drug reactions. The 40 mg group had a significantly lower rate of relapse (p 0.05), and a greater increase in the number of abstinent days/week (p 0.09), than the other treatment groups. A significant decrease in the number of drinks/drinking day was noted for both nalmefene groups (p 0.04), but not for placebo. These results were supported by parallel decreases in ALT. These pilot data provide preliminary support for the hypotheses that nalmefene can be safely given to alcoholics, and that nalmefene may have a role in reducing alcohol consumption and preventing relapse, particularly at the 40 mg level. A full-scale study is underway to confirm these preliminary findings." @default.
• W2050538748 created "2016-06-24" @default.
• W2050538748 creator A5000616093 @default.
• W2050538748 creator A5015598472 @default.
• W2050538748 creator A5025693707 @default.
• W2050538748 creator A5026624213 @default.
• W2050538748 creator A5072669607 @default.
• W2050538748 creator A5075643469 @default.
• W2050538748 creator A5085618854 @default.
• W2050538748 date "1994-10-01" @default.
• W2050538748 modified "2023-10-16" @default.
• W2050538748 title "A Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol Dependence" @default.
• W2050538748 cites W1976153901 @default.
• W2050538748 cites W1995795577 @default.
• W2050538748 cites W2001345670 @default.
• W2050538748 cites W2018121893 @default.
• W2050538748 cites W2027307035 @default.
• W2050538748 cites W2041546498 @default.
• W2050538748 cites W2044293558 @default.
• W2050538748 cites W2045284958 @default.
• W2050538748 cites W2060200544 @default.
• W2050538748 cites W2064447763 @default.
• W2050538748 cites W2072709970 @default.
• W2050538748 cites W2086368973 @default.
• W2050538748 cites W2093559862 @default.
• W2050538748 cites W2104538950 @default.
• W2050538748 cites W2114613490 @default.
• W2050538748 cites W2119226169 @default.
• W2050538748 cites W2166104912 @default.
• W2050538748 cites W2485641404 @default.
• W2050538748 cites W2925220137 @default.
• W2050538748 doi "https://doi.org/10.1111/j.1530-0277.1994.tb00098.x" @default.
• W2050538748 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7847600" @default.
• W2050538748 hasPublicationYear "1994" @default.
• W2050538748 type Work @default.
• W2050538748 sameAs 2050538748 @default.
• W2050538748 citedByCount "241" @default.
• W2050538748 countsByYear W20505387482012 @default.
• W2050538748 countsByYear W20505387482013 @default.
• W2050538748 countsByYear W20505387482014 @default.
• W2050538748 countsByYear W20505387482015 @default.
• W2050538748 countsByYear W20505387482016 @default.
• W2050538748 countsByYear W20505387482017 @default.
• W2050538748 countsByYear W20505387482018 @default.
• W2050538748 countsByYear W20505387482019 @default.
• W2050538748 countsByYear W20505387482020 @default.
• W2050538748 countsByYear W20505387482021 @default.
• W2050538748 countsByYear W20505387482022 @default.
• W2050538748 countsByYear W20505387482023 @default.
• W2050538748 crossrefType "journal-article" @default.
• W2050538748 hasAuthorship W2050538748A5000616093 @default.
• W2050538748 hasAuthorship W2050538748A5015598472 @default.
• W2050538748 hasAuthorship W2050538748A5025693707 @default.
• W2050538748 hasAuthorship W2050538748A5026624213 @default.
• W2050538748 hasAuthorship W2050538748A5072669607 @default.
• W2050538748 hasAuthorship W2050538748A5075643469 @default.
• W2050538748 hasAuthorship W2050538748A5085618854 @default.
• W2050538748 hasConcept C126322002 @default.
• W2050538748 hasConcept C142724271 @default.
• W2050538748 hasConcept C170493617 @default.
• W2050538748 hasConcept C185592680 @default.
• W2050538748 hasConcept C197934379 @default.
• W2050538748 hasConcept C202061045 @default.
• W2050538748 hasConcept C204787440 @default.
• W2050538748 hasConcept C27081682 @default.
• W2050538748 hasConcept C2776885963 @default.
• W2050538748 hasConcept C2777972943 @default.
• W2050538748 hasConcept C2778140631 @default.
• W2050538748 hasConcept C2778836221 @default.
• W2050538748 hasConcept C2779436514 @default.
• W2050538748 hasConcept C2781066024 @default.
• W2050538748 hasConcept C2991744798 @default.
• W2050538748 hasConcept C3019635848 @default.
• W2050538748 hasConcept C42219234 @default.
• W2050538748 hasConcept C55493867 @default.
• W2050538748 hasConcept C71924100 @default.
• W2050538748 hasConcept C98274493 @default.
• W2050538748 hasConceptScore W2050538748C126322002 @default.
• W2050538748 hasConceptScore W2050538748C142724271 @default.
• W2050538748 hasConceptScore W2050538748C170493617 @default.
• W2050538748 hasConceptScore W2050538748C185592680 @default.
• W2050538748 hasConceptScore W2050538748C197934379 @default.
• W2050538748 hasConceptScore W2050538748C202061045 @default.
• W2050538748 hasConceptScore W2050538748C204787440 @default.
• W2050538748 hasConceptScore W2050538748C27081682 @default.
• W2050538748 hasConceptScore W2050538748C2776885963 @default.
• W2050538748 hasConceptScore W2050538748C2777972943 @default.
• W2050538748 hasConceptScore W2050538748C2778140631 @default.
• W2050538748 hasConceptScore W2050538748C2778836221 @default.
• W2050538748 hasConceptScore W2050538748C2779436514 @default.
• W2050538748 hasConceptScore W2050538748C2781066024 @default.
• W2050538748 hasConceptScore W2050538748C2991744798 @default.
• W2050538748 hasConceptScore W2050538748C3019635848 @default.
• W2050538748 hasConceptScore W2050538748C42219234 @default.
• W2050538748 hasConceptScore W2050538748C55493867 @default.
• W2050538748 hasConceptScore W2050538748C71924100 @default.
• W2050538748 hasConceptScore W2050538748C98274493 @default.
• W2050538748 hasIssue "5" @default.

• next